Last updated: April 2026
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.
Affiliate Disclosure: We may earn a commission when you purchase through our links. This does not affect our editorial independence.
Quick Answer
- Hyperbaric oxygen therapy (HBOT) treats conditions like air embolism, which can occur from an ascent of as little as one meter during diving.
- The Undersea & Hyperbaric Medical Society (UHMS) lists 14 approved indications for HBOT, including carbon monoxide poisoning and problem wounds.
- The FDA recommends seeking HBOT at UHMS-accredited facilities for specific illnesses to ensure safety and quality.
- Gas embolism can result from medical procedures such as laparoscopy, transurethral surgery, and central venous catheter placement, where even a continuous IV infusion of oxygen at 20 mL/min caused symptoms in humans.
Hyperbaric oxygen therapy (HBOT) is a specialized medical treatment where patients breathe 100% oxygen in a pressurized chamber. This therapy is crucial for addressing various conditions, including life-threatening emergencies like air or gas embolism. For instance, pulmonary barotrauma and gas embolism can happen from breath holding during an ascent of as little as one meter while diving, making prompt HBOT essential for recovery Undersea & Hyperbaric Medical Society HBO Indications. The Undersea & Hyperbaric Medical Society (UHMS) is the leading authority in this field, outlining 14 specific indications where HBOT is recognized as an effective treatment. To ensure patient safety and the highest quality of care, the U.S. Food & Drug Administration (FDA) advises individuals to seek HBOT at facilities that have earned UHMS accreditation for treating particular illnesses. Understanding the approved uses and the importance of accredited facilities can help prevent malpractice and ensure patients receive appropriate, evidence-based care.
What is Hyperbaric Oxygen Therapy (HBOT)?
Hyperbaric oxygen therapy (HBOT) is a medical treatment that involves breathing pure, 100% oxygen within a specially designed chamber where the atmospheric pressure is increased. This elevated pressure allows the blood plasma to absorb significantly more oxygen than it would under normal atmospheric conditions. This highly oxygenated blood can then reach areas of the body that are struggling due to injury, infection, or poor circulation, promoting healing and reducing inflammation. The core principle behind HBOT is to deliver oxygen at a therapeutic level that cannot be achieved through other methods, thereby supporting the body's natural healing processes and combating certain pathological conditions. It is a precise medical intervention requiring specialized equipment and trained personnel to administer safely and effectively.
The Undersea & Hyperbaric Medical Society (UHMS) serves as the primary scientific and medical organization that defines and reviews the accepted uses for hyperbaric oxygen therapy. The UHMS is dedicated to promoting research and education in undersea and hyperbaric medicine. Their guidelines and publications are considered the gold standard for clinical practice in this field. They meticulously review scientific evidence to establish which medical conditions can genuinely benefit from HBOT. This rigorous process ensures that the therapy is used appropriately and based on solid medical data, rather than anecdotal claims. The UHMS has consistently updated its recommendations, reflecting ongoing research and advancements in the field.
In our analysis, we rely heavily on the comprehensive documentation provided by the UHMS. For instance, the UHMS has published multiple editions of its authoritative report, "Hyperbaric Oxygen Therapy Indications," with the current definitive guide being the 14th Edition. This extensive document details the specific conditions for which HBOT is considered an approved and effective treatment UHMS Hyperbaric Oxygen Therapy Indications 14th Edition. The continuous updates to this publication highlight the dynamic nature of medical science and the society's commitment to providing the most current and evidence-based information. Each edition incorporates new research findings and refines existing recommendations, ensuring that practitioners and patients have access to the most accurate guidance available.
The 13th Edition of the UHMS "Hyperbaric Oxygen Therapy Indications" also outlined key areas of treatment in its Part I, including Air or Gas Embolism, Arterial Insufficiencies (specifically Central Retinal Artery Occlusion and Enhancement of Healing in Selected Problem Wounds), Carbon Monoxide Poisoning, Clostridial Myonecrosis (Gas Gangrene), and Compromised Grafts and Flaps UHMS Hyperbaric Oxygen Therapy Indications 13th Edition. These specific examples from an earlier edition illustrate the breadth of conditions addressed by HBOT and the detailed categorization provided by the UHMS. The evolution from the 13th to the 14th edition signifies a continuous effort to refine and expand the understanding and application of this therapy.
Understanding the definition and the authoritative backing of HBOT is critical for both patients and healthcare providers. It differentiates legitimate, evidence-based applications of the therapy from unproven or experimental uses. The UHMS's role in defining and reviewing these indications is paramount for maintaining safety standards and ensuring that HBOT remains a respected and effective medical intervention. Without such a robust framework, the therapy could be misused, leading to ineffective treatments or, worse, patient harm. Therefore, adherence to UHMS guidelines is a cornerstone of responsible hyperbaric medicine practice.
The Role of Pressure and Oxygen
HBOT chambers increase ambient pressure to typically 2 to 3 times normal atmospheric pressure. This increased pressure, combined with breathing 100% oxygen, causes oxygen to dissolve directly into the blood plasma, cerebrospinal fluid, and other body fluids, bypassing the hemoglobin in red blood cells that normally carry oxygen. This mechanism allows oxygen to reach tissues that are starved of oxygen due to poor circulation, swelling, or injury. The dissolved oxygen can then promote new blood vessel growth, reduce swelling, fight infection, and support tissue repair.
UHMS as the Authority
The Undersea & Hyperbaric Medical Society is an international non-profit organization that serves as a primary source for scientific and medical information on hyperbaric oxygen therapy. Their rigorous process for accepting new indications for HBOT involves extensive review by a committee of experts. This ensures that any condition approved for HBOT has sufficient scientific evidence to support its efficacy and safety. The UHMS guidelines are frequently used by insurance companies and regulatory bodies to determine coverage and appropriate use of HBOT.
What are the Approved Indications for HBOT?
The Undersea & Hyperbaric Medical Society (UHMS) has established a definitive list of approved indications for hyperbaric oxygen therapy (HBOT), which are widely recognized as the standard for clinical practice. These indications represent medical conditions where HBOT has demonstrated clear therapeutic benefits supported by scientific evidence. The UHMS actively works to ensure these guidelines are current and reflect the latest research, providing a critical framework for safe and effective treatment.
There are 14 specific indications for HBOT listed in the UHMS 14th Edition of "Hyperbaric Oxygen Therapy Indications" UHMS Hyperbaric Oxygen Therapy Indications 14th Edition. These conditions range from acute emergencies to chronic issues that have not responded to conventional treatments. The comprehensive nature of this list underscores the diverse applications of HBOT in modern medicine. Each indication has a detailed chapter within the UHMS report, outlining the scientific basis, treatment protocols, and expected outcomes.
Among the primary approved indications is Air or Gas Embolism. This life-threatening condition occurs when gas bubbles enter the bloodstream, potentially blocking blood flow to vital organs. HBOT is crucial here because the increased pressure helps to reduce the size of the gas bubbles, allowing them to pass through capillaries and be reabsorbed by the body. Another critical indication is Carbon Monoxide Poisoning, where HBOT helps to rapidly remove carbon monoxide from the bloodstream and restore oxygen delivery to tissues, mitigating the severe neurological and cardiac damage that can result from this type of poisoning.
Decompression Sickness, commonly known as "the bends," is another well-known indication, particularly relevant for divers. This condition arises when dissolved gases form bubbles in the body due to a rapid decrease in ambient pressure. HBOT helps to recompress these bubbles and facilitate their safe removal from the body. Beyond these acute conditions, HBOT is also approved for certain types of Problem Wounds, especially those that are chronic, non-healing, or complicated by infection or poor circulation. Examples include diabetic foot ulcers and certain types of pressure sores. The increased oxygen delivery promotes healing, new tissue growth, and reduces bacterial load in these challenging wounds.
Other approved indications include Clostridial Myonecrosis (Gas Gangrene), a severe bacterial infection that produces gas in tissues. HBOT creates an oxygen-rich environment that is toxic to the anaerobic bacteria causing the infection and aids in tissue preservation. Compromised Grafts and Flaps also benefit from HBOT, as it helps to ensure the viability of transplanted tissues by improving oxygen supply and circulation to the area, reducing the risk of tissue loss. Similarly, Acute Traumatic Ischemias, such as crush injuries or sudden arterial blockages, can be treated with HBOT to salvage damaged tissues and prevent amputation by enhancing oxygenation and reducing swelling.
The list extends to include Central Retinal Artery Occlusion, a sudden blockage of the main artery supplying blood to the retina, which can cause rapid vision loss. HBOT can help restore blood flow and oxygen to the retina. Delayed Radiation Injuries, which can manifest as soft tissue or bony necrosis long after radiation therapy, are also treated with HBOT to promote healing and repair damaged tissues. Sudden Sensorineural Hearing Loss is another indication where HBOT may improve hearing outcomes, particularly when administered shortly after onset.
Furthermore, HBOT is indicated for Intracranial Abscess, a collection of pus within the brain, where it acts as an adjunct to antibiotics and surgery by improving oxygen delivery to infected tissues and enhancing the effectiveness of antibiotics. Necrotizing Soft Tissue Infections, which are rapidly spreading and destructive infections, benefit from HBOT's ability to create an oxygen-rich environment that inhibits bacterial growth and supports the immune response. Refractory Osteomyelitis, a persistent bone infection that doesn't respond to standard treatments, can also be addressed with HBOT to improve oxygenation of the infected bone, enhancing antibiotic penetration and promoting bone healing. See the intracranial abscess evidence atlas for the full study-by-study evidence breakdown.
Finally, Severe Anemia where blood transfusions are not possible or are contraindicated, can sometimes be managed with HBOT to provide sufficient oxygen to tissues while the underlying cause of anemia is addressed. Adjunctive Hyperbaric Oxygen Therapy in the Treatment of Thermal Burns helps to reduce swelling, promote healing, and minimize the need for surgery in severe burn cases. This comprehensive list of 14 indications underscores the critical role HBOT plays in treating a wide array of complex medical conditions, all backed by the rigorous standards of the UHMS. See the severe anemia evidence atlas for the full study-by-study evidence breakdown.
Adherence to UHMS Guidelines
Adherence to these UHMS-approved indications is paramount for ethical and effective HBOT practice. Treating conditions not on this list is considered "off-label" and may not be covered by insurance, and more importantly, may lack the scientific evidence to support its efficacy or safety. This distinction is crucial for both patient safety and preventing potential malpractice claims. Clinics offering HBOT for unapproved conditions should be approached with caution.
The Importance of Evidence
Each of the 14 approved indications has undergone extensive review, including systematic reviews of clinical trials and observational studies. This evidence-based approach ensures that HBOT is not just a theoretical treatment but a proven intervention for these specific health challenges. The UHMS committee, comprised of leading experts in hyperbaric medicine, continuously evaluates new research to update these guidelines, making them a living document that evolves with scientific discovery.
How Does Air or Gas Embolism Occur, and How is HBOT Used?
Air or gas embolism is a serious medical condition that arises when gas bubbles enter the body's arteries or veins, potentially obstructing blood flow and causing severe, life-threatening damage to tissues and organs. Understanding how these embolisms occur is crucial for prevention and for appreciating the vital role hyperbaric oxygen therapy (HBOT) plays in their treatment. HBOT is a primary intervention for gas embolism due to its ability to rapidly reduce bubble size and facilitate their reabsorption, restoring proper circulation.
Gas embolism fundamentally occurs when gas bubbles, typically air, are introduced into the circulatory system. Richard E. Moon, in the "Hyperbaric Oxygen Therapy Indications: Air or Gas Embolism" chapter, explains that arterial gas embolism (AGE) was first observed in submarine escape training. In these scenarios, pulmonary barotrauma, which is lung injury caused by pressure changes, happened during free ascent after breathing compressed gas at depth. This can even occur from an ascent of as little as one meter if breath holding occurs after breathing compressed gas Undersea & Hyperbaric Medical Society HBO Indications. This highlights how even seemingly minor pressure changes can trigger a dangerous embolism in susceptible individuals. AGE has also been linked to normal ascents in divers who have underlying lung conditions like bullous disease or asthma, indicating that pre-existing vulnerabilities can increase risk.
Venous gas embolism (VGE) is another common form, particularly after compressed gas diving. Normally, VGE bubbles are trapped by the pulmonary capillaries in the lungs and do not cause noticeable symptoms. However, if the volume of gas is large enough, these bubbles can overwhelm the capacity of the pulmonary capillary network. When this happens, bubbles can bypass the lungs and enter the arterial circulation, leading to more widespread and severe clinical problems. Large volumes of VGE can also cause symptoms such as cough, dyspnea (shortness of breath), and pulmonary edema (fluid in the lungs). Furthermore, VGE can directly enter the left side of the heart through structural heart defects like an atrial septal defect or a patent foramen ovale, bypassing the pulmonary filter entirely and immediately leading to arterial embolism.
Beyond diving-related incidents, gas embolism can stem from a wide array of medical and surgical procedures, as well as accidental exposures. Accidental intravenous air injection, for example, is a known cause. Cardiopulmonary bypass accidents during heart surgery, needle biopsies of the lung, hemodialysis, and central venous catheter placement or disconnection are all recognized sources of gas entry into the bloodstream. Gastrointestinal endoscopy, irrigation or ingestion of hydrogen peroxide, arthroscopy, and cardiopulmonary resuscitation have also been implicated. Even non-medical scenarios like blowing air into the vagina during orogenital sex or sexual intercourse after childbirth can lead to air embolism. These diverse origins underscore the varied circumstances under which this critical condition can arise.
The severity of symptoms depends on the type and volume of gas introduced. While intravenous injection is often asymptomatic, clinical deficits can occur after intra-arterial injection of even small volumes of air. In experimental animals, injection of up to 0.5-1 mL/kg has been tolerated. In humans, continuous intravenous infusion of oxygen at 10 mL/min has been reported as well tolerated, but 20 mL/min caused symptoms. This suggests that the rate and volume of gas entry are crucial factors in determining the clinical outcome. Injections of air are generally more likely to cause clinical abnormalities compared to constant infusions.
HBOT is the definitive treatment for gas embolism because it addresses the underlying problem directly. The increased ambient pressure in the hyperbaric chamber physically compresses the gas bubbles, reducing their size. This allows the bubbles to pass through constricted blood vessels that they previously blocked. Moreover, breathing 100% oxygen at high pressure increases the partial pressure of oxygen in the blood, which helps to accelerate the dissolution of nitrogen (the primary component of air bubbles) from the bubbles back into the blood. This process, known as the "oxygen window effect," facilitates the rapid reabsorption of the gas bubbles by the body, clearing the obstruction and restoring blood flow to oxygen-deprived tissues. Early administration of HBOT is critical for improving patient outcomes and minimizing permanent damage.
Mechanisms of Gas Embolism
Gas embolism can occur through several mechanisms. In diving, it's typically due to Boyle's Law, where gas expands as pressure decreases during ascent. If a diver holds their breath, the expanding gas in the lungs can rupture alveoli, forcing gas into the pulmonary circulation and then into the arterial system. In medical settings, it often involves direct introduction of air into vessels, either accidentally during procedures or when negative pressure in veins during surgery draws air in.
HBOT's Role in Treatment
Upon suspicion of gas embolism, immediate HBOT is indicated. The treatment typically involves recompressing the patient to a pressure equivalent to 60 feet of seawater (approximately 2.8 atmospheres absolute) while breathing 100% oxygen. This high pressure shrinks the bubbles, making them less obstructive. The oxygen helps to wash out inert gases like nitrogen from the bubbles, allowing them to dissolve back into the blood and be exhaled. Subsequent treatments at lower pressures may be necessary depending on the patient's response and the severity of the embolism.
What Procedures Can Lead to Gas Embolism Requiring HBOT?
Gas embolism is not exclusively a diving-related injury; it can also be a significant complication of various medical and surgical procedures. In our review, we have identified several common medical interventions that carry a risk of introducing gas into the circulatory system, potentially necessitating hyperbaric oxygen therapy (HBOT). These procedural embolisms often occur due to specific techniques or physiological circumstances during surgery or diagnostic procedures.
Many procedures where the surgical site is under pressure pose a risk of gas embolism. This includes laparoscopic surgeries, where carbon dioxide gas is insufflated into the abdominal cavity to create space for visualization and manipulation of organs. If the gas pressure is too high, or if there is accidental injury to a blood vessel, gas can enter the circulation. Transurethral surgery and vitrectomy (eye surgery) also involve pressurized environments where gas embolism can occur. Similarly, hysteroscopy, a procedure to examine the inside of the uterus, can lead to gas embolism if air or fluid containing gas is introduced into the uterine cavity and subsequently enters the bloodstream. These procedures require meticulous attention to pressure management and careful monitoring to prevent such complications.
Massive venous gas embolism (VGE) can also happen due to the passive entry of air into surgical wounds, especially when these wounds are elevated above the level of the heart. In such positions, the pressure in adjacent veins can become subatmospheric, essentially creating a vacuum that draws air into the open vessels. This phenomenon has been classically described in sitting craniotomy, a neurosurgical procedure where the patient's head is elevated to improve surgical access. The negative pressure in the cerebral veins can easily entrain air, leading to a significant VGE.
Beyond craniotomy, this risk extends to other surgical fields. For instance, VGE has been reported during cesarean section, particularly when the uterus is elevated or manipulated. Prostatectomy, using both the radical perineal and retropubic approaches, can also create conditions for air entry into veins. Spine surgery, especially when performed with the patient in a prone or sitting position, carries a substantial risk due to the potential for negative venous pressure. Other orthopedic procedures like hip replacement have also been associated with VGE.
Furthermore, complex abdominal surgeries such as liver resection and liver transplantation can involve large, open surgical fields and significant blood loss, increasing the opportunity for air entrainment into veins. Even less invasive procedures like the insertion of dental implants have been implicated as a cause of gas embolism. This broad spectrum of procedures highlights the pervasive risk of gas embolism across many medical specialties, emphasizing the need for vigilance and appropriate preventative measures.
The clinical presentation of gas embolism can vary widely, depending on the volume of gas, the rate of entry, and whether the embolism is arterial or venous. Arterial gas embolism (AGE) is generally more severe due to the direct impact on vital organs like the brain and heart. Even small volumes of air injected intra-arterially can cause significant clinical deficits, such as neurological impairment or cardiac arrest. In contrast, intravenous injection is often asymptomatic unless the volume is large enough to overwhelm the pulmonary filtering capacity or a patent foramen ovale is present. In our research, we found that continuous IV infusion of oxygen at 10 mL/min has been tolerated in humans, while 20 mL/min caused symptoms, demonstrating a threshold for clinical impact related to volume and rate of gas introduction.
When gas embolism occurs, HBOT becomes a critical, often life-saving, intervention. The hyperbaric environment physically compresses the gas bubbles, reducing their size and making them less obstructive. The high concentration of oxygen also helps to dissolve the inert gas (primarily nitrogen) from the bubbles back into the bloodstream, where it can be safely exhaled. This rapid reduction in bubble size and volume is essential for restoring blood flow to compromised tissues and preventing further damage. Early recognition and immediate transfer to a hyperbaric facility are paramount for optimizing patient outcomes following procedural gas embolism.
Minimizing Risk During Procedures
Surgeons and anesthesiologists employ various strategies to minimize the risk of gas embolism during high-risk procedures. These include maintaining positive end-expiratory pressure (PEEP) during mechanical ventilation, keeping the surgical field flooded with saline, careful monitoring for changes in end-tidal carbon dioxide, and using Doppler ultrasound to detect venous air. Despite these precautions, embolisms can still occur, underscoring the importance of rapid diagnosis and access to HBOT.
Surgical Site Pressure Management
In procedures like laparoscopy, careful management of insufflation pressure is vital. The pressure of the gas used to distend the surgical cavity must be carefully controlled to prevent gas from entering compromised vessels. Similarly, in other surgeries, ensuring that veins are not exposed to subatmospheric pressure is a key preventative measure. This often involves careful patient positioning and prompt ligation or cauterization of open vessels.
Why is Accreditation Important for HBOT Facilities?
Accreditation for hyperbaric oxygen therapy (HBOT) facilities is of paramount importance for ensuring patient safety, quality of care, and adherence to established medical standards. The complex nature of HBOT, which involves pressurized environments and pure oxygen, necessitates rigorous protocols and highly trained personnel to minimize risks and maximize therapeutic benefits. Without proper oversight, there is a significant potential for errors, equipment malfunctions, or treatments administered for unproven conditions, all of which can compromise patient well-being.
The U.S. Food & Drug Administration (FDA) explicitly recognizes the critical role of accreditation in this specialized field. The FDA recommends using UHMS-accredited hyperbaric facilities for treating specific illnesses FDA Recommendation for UHMS-Accredited Facilities. This recommendation is not merely a suggestion; it serves as a strong endorsement of the Undersea & Hyperbaric Medical Society's (UHMS) accreditation program as a benchmark for excellence and safety. The FDA's stance underscores the belief that UHMS accreditation signifies a facility's commitment to the highest standards of care.
Accreditation helps ensure patient safety by verifying that a facility meets stringent criteria across various domains. These criteria typically cover personnel qualifications, equipment maintenance, safety protocols, and emergency procedures. For instance, an accredited facility will have physicians, nurses, and technicians who are specifically trained and certified in hyperbaric medicine. They understand the physiological effects of hyperbaric environments, how to manage potential complications such as oxygen toxicity or barotrauma, and how to operate the specialized hyperbaric chambers safely. This level of expertise is crucial, as improper operation or inadequate staff training can lead to severe adverse events.
The UHMS offers a comprehensive Hyperbaric Facility Accreditation Program designed to evaluate and certify facilities that meet its stringent standards. This program involves a thorough review of a facility's policies, procedures, staffing, and equipment. For example, the program assesses the maintenance schedule for hyperbaric chambers, ensuring that they are regularly inspected and serviced to prevent mechanical failures. It also scrutinizes emergency preparedness plans, including protocols for fire in an oxygen-rich environment, which is a unique and significant risk in HBOT. Facilities seeking accreditation must demonstrate a robust safety culture and a commitment to continuous quality improvement.
Quality of care is also directly enhanced by accreditation. Accredited facilities are more likely to adhere to the UHMS-approved indications for HBOT, meaning they provide treatments that are scientifically proven to be effective. This prevents patients from undergoing costly and potentially harmful treatments for conditions where HBOT has no established benefit. The accreditation process encourages evidence-based practice, ensuring that treatment plans are tailored to individual patient needs based on the latest medical research. In our experience, facilities that undergo accreditation often have better patient outcomes due to their adherence to best practices and their focus on continuous improvement.
Furthermore, accreditation provides a level of assurance for patients and referring physicians. When a facility is UHMS-accredited, it signals that an independent, authoritative body has thoroughly vetted its operations. This can instill confidence that the facility is operating ethically, safely, and effectively. For referring physicians, it simplifies the decision-making process, as they can confidently send their patients to facilities that meet recognized standards. In an industry where unproven therapies can sometimes be marketed, accreditation acts as a vital safeguard against misleading claims and substandard care. Choosing an accredited facility is a proactive step patients can take to protect their health and ensure they receive appropriate, high-quality hyperbaric oxygen therapy.
The Accreditation Process
The UHMS accreditation process is rigorous and typically involves self-assessment, an on-site visit by a team of experts, and a detailed review of all aspects of the hyperbaric program. Facilities must demonstrate compliance with strict safety standards, clinical protocols, and staff training requirements. This comprehensive evaluation ensures that only facilities meeting the highest benchmarks receive accreditation.
Benefits for Patients
For patients, choosing an accredited facility means they are more likely to receive care that is evidence-based, administered by qualified professionals, and performed in a safe environment. It minimizes the risk of complications and increases the likelihood of a successful treatment outcome. Accreditation also often correlates with better administrative practices, including transparent billing and clear communication about treatment plans.
What are the Risks if HBOT is Not Administered Correctly?
The administration of hyperbaric oxygen therapy (HBOT) is a highly specialized medical procedure that requires precise control over pressure, oxygen concentration, and treatment duration. If HBOT is not administered correctly, the risks to patient health can be substantial, ranging from minor discomfort to severe injury or even death. The unique environment of a hyperbaric chamber, with its elevated pressure and pure oxygen atmosphere, introduces specific hazards that must be meticulously managed by trained professionals.
One of the primary risks associated with incorrect HBOT administration is barotrauma. This refers to tissue damage caused by changes in pressure. If the pressure within the chamber is not gradually increased or decreased, or if a patient has an inability to equalize pressure in air-filled cavities, barotrauma can occur. Common sites for barotrauma include the ears (middle ear squeeze), sinuses, and lungs (pulmonary barotrauma). Pulmonary barotrauma, in particular, can be severe, potentially leading to a collapsed lung (pneumothorax) or arterial gas embolism, which, as discussed, is a life-threatening condition.
Another significant risk is oxygen toxicity. While oxygen is essential for life, breathing 100% oxygen at elevated pressures for extended periods can be toxic to the central nervous system and the lungs. Central nervous system oxygen toxicity can manifest as visual changes, ringing in the ears, nausea, muscle twitching, irritability, dizziness, and convulsions. Pulmonary oxygen toxicity can lead to inflammation and damage to lung tissue, reducing lung capacity. These risks are carefully managed in correctly administered HBOT by controlling the treatment pressure, duration, and incorporating air breaks during which patients breathe ambient air to reduce oxygen exposure. Incorrect protocols, such as exceeding safe pressure limits or treatment times, dramatically increase the likelihood of oxygen toxicity.
The Undersea and Hyperbaric Medical Society (UHMS) and Best Publishing Company explicitly state the gravity of these risks. They issue a clear caution in the Thirteenth Edition of the "Hyperbaric Oxygen Therapy Indications": "No responsibility is assumed by the Publisher or Editor for any injury and or damage to persons or property as a matter of product liability, negligence or otherwise, or from any use or operation of any methods, product, instructions, or ideas contained in the material herein." This statement, attributed to Lindell K. Weaver MD, Chair and Editor, Undersea and Hyperbaric Medical Society, Thirteenth Edition, underscores that the responsibility for safe practice lies squarely with the practitioners administering the therapy. It highlights the potential for serious consequences if methods, products, or instructions are used incorrectly or negligently.
Beyond physiological risks, there are also operational hazards. The high-oxygen environment within a hyperbaric chamber presents a significant fire risk. Any source of ignition, such as static electricity, an unapproved electronic device, or even certain fabrics, can lead to a catastrophic fire. Strict safety protocols, including banning all flammable materials and ensuring proper grounding, are essential. If these protocols are not rigorously followed due to negligence or inadequate training, the consequences can be devastating for patients and staff alike.
Furthermore, the UHMS and Best Publishing Company emphasize the need for professional judgment: "No suggested test or procedure should be carried out unless, in the reader’s judgment, its risk is justified." This means that practitioners must constantly evaluate the risks versus benefits for each patient, considering their individual health status and the specifics of the HBOT treatment. They also recommend "independent verification of diagnoses and drug dosages" due to rapid advances in medical sciences. This recommendation highlights that even with established guidelines, constant vigilance and ongoing education are necessary to ensure patient safety and to adapt to new medical knowledge. Failing to perform such independent verification or to exercise sound medical judgment can be a significant source of malpractice.
In essence, incorrect administration of HBOT, whether through deviation from established protocols, inadequate staff training, faulty equipment, or poor clinical judgment, can transform a potentially life-saving treatment into a dangerous one. The complex interplay of pressure, oxygen, and patient physiology demands an exceptionally high standard of care. Any clinic or practitioner that fails to meet these standards not only puts patients at risk but also opens themselves up to significant liability for malpractice.
Importance of Training and Protocols
Proper training for all hyperbaric staff, including physicians, nurses, and technicians, is non-negotiable. This training covers chamber operation, patient monitoring, emergency procedures, and the recognition and management of complications. Strict adherence to established treatment protocols, such as those outlined by the UHMS, is essential to minimize risks like oxygen toxicity and barotrauma.
Equipment Maintenance and Safety
Regular maintenance and calibration of hyperbaric chambers and associated equipment are critical. Malfunctioning equipment, such as faulty pressure gauges or oxygen delivery systems, can lead to unsafe conditions. Facilities must have robust safety checklists and procedures for daily, weekly, and annual inspections to ensure all equipment is in optimal working order and meets safety standards.
Frequently Asked Questions
What is the primary purpose of hyperbaric oxygen therapy?
The primary purpose of hyperbaric oxygen therapy (HBOT) is to deliver high concentrations of oxygen to the body's tissues at increased atmospheric pressure. This allows oxygen to dissolve directly into the blood plasma, reaching areas with compromised blood flow or infection. For instance, in cases of air or gas embolism, HBOT rapidly shrinks gas bubbles, and breathing 100% oxygen helps to dissolve inert gases like nitrogen from the bubbles, restoring circulation to vital organs.
How many conditions are officially recognized for HBOT by the UHMS?
The Undersea & Hyperbaric Medical Society (UHMS) officially recognizes 14 specific medical conditions for which hyperbaric oxygen therapy (HBOT) is an approved treatment. These indications are detailed in the UHMS's "Hyperbaric Oxygen Therapy Indications," with the current authoritative guide being the 14th Edition. This list includes conditions such as carbon monoxide poisoning, decompression sickness, and problem wounds, all backed by scientific evidence.
Can HBOT treat conditions other than diving-related injuries?
Yes, HBOT can treat many conditions beyond diving-related injuries. While it is well-known for treating decompression sickness and air or gas embolism, the UHMS lists 14 approved indications. These include non-diving conditions like severe anemia, delayed radiation injuries, necrotizing soft tissue infections, and certain types of problem wounds like diabetic foot ulcers. The 13th Edition of the UHMS indications, for example, lists Central Retinal Artery Occlusion as an arterial insufficiency treatable by HBOT.
Why is UHMS accreditation important for an HBOT facility?
UHMS accreditation is crucial for an HBOT facility because it ensures patient safety and the quality of care provided. The FDA recommends using UHMS-accredited hyperbaric facilities for treating specific illnesses, recognizing that accreditation verifies a facility meets stringent standards for personnel qualifications, equipment maintenance, safety protocols, and emergency procedures. This helps to prevent malpractice and ensures treatments are administered by trained professionals according to established, evidence-based guidelines.
What are some common causes of gas embolism that HBOT can treat?
Gas embolism can arise from various causes, both diving-related and medical. Diving-related causes include pulmonary barotrauma from breath holding during ascent, even from as little as one meter. Medical causes are diverse and include accidental intravenous air injection, cardiopulmonary bypass accidents, needle biopsy of the lung, central venous catheter placement or disconnection, and surgical procedures like laparoscopy, transurethral surgery, and sitting craniotomy. HBOT is a primary treatment for all these forms of gas embolism.
Sources
- https://www.uhms.org/resources/featured-resources/hbo-indications.html
- https://www.uhms.org/images/UHMS-Reference-Material.pdf
- https://www.uhms.org/images/indications/UHMS_HBO2_Indications_13th_Ed._Front_Matter__References.pdf
- https://www.uhms.org/hu/resources/news-announcements/1104-fda-recommends-uhms-accredited-hyperbaric-facilities-for-treatment-of-specific-illnesses.html
Related Reading
- Does Insurance Cover Hyperbaric Oxygen Therapy?
- Medicare HBOT Coverage: The 14 Approved Indications
- Hyperbaric Oxygen Therapy for Pets: A Guide to Veterinary HBOT
- 15 Questions to Ask Before Starting Hyperbaric Oxygen Therapy [2026]
- Best Hyperbaric Oxygen Therapy in Chicago 2026
— The HBOT Finder Team